{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2019-nCoV", "6VSB", "6W01", "Corona virus", "In-silico", "Saikosaponins", "Traditional Chinese Medicine", "molecular docking", "virtual screening"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32345124", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "18"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2020.1762741"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "39", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Jun"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "An <i>in-silico</i> evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets.", "Pagination": {"StartPage": "3244", "EndPage": "3255", "MedlinePgn": "3244-3255"}, "Abstract": {"AbstractText": ["The Public Health Emergency of International Concern declared the widespread outbreak of SARS-CoV-2 as a global pandemic emergency, which has resulted in 1,773,086 confirmed cases including 111,652 human deaths, as on 13 April 2020, as reported to World Health Organization. As of now, there are no vaccines or antiviral drugs declared to be officially useful against the infection. Saikosaponin is a group of oleanane derivatives reported in Chinese medicinal plants and are described for their anti-viral, anti-tumor, anti-inflammatory, anticonvulsant, antinephritis and hepatoprotective activities. They have also been known to have anti-coronaviral property by interfering the early stage of viral replication including absorption and penetration of the virus. Thus, the present study was undertaken to screen and evaluate the potency of different Saikosaponins against different sets of SARS-CoV-2 binding protein <i>via</i> computational molecular docking simulations. Docking was carried out on a Glide module of Schrodinger Maestro 2018-1\u2009MM Share Version on NSP15 (PDB ID: 6W01) and Prefusion 2019-nCoV spike glycoprotein (PDB ID: 6VSB) from SARS-CoV-2. From the binding energy and interaction studies, the Saikosaponins U and V showed the best affinity towards both the proteins suggesting them to be future research molecule as they mark the desire interaction with NSP15, which is responsible for replication of RNA and also with 2019-nCoV spike glycoprotein which manage the connection with ACE2. [Formula: see text] Communicated by Ramaswamy H. Sarma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Mohanlal Shukhadia University, Udaipur, India."}], "LastName": "Sinha", "ForeName": "Saurabh K", "Initials": "SK"}, {"Identifier": ["0000-0002-8232-4476"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Engineering, Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India."}], "LastName": "Shakya", "ForeName": "Anshul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, R.T.M. University, Nagpur, India."}], "LastName": "Prasad", "ForeName": "Satyendra K", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Varanasi Collage of Pharmacy, Varanasi, India."}], "LastName": "Singh", "ForeName": "Shashikant", "Initials": "S"}, {"Identifier": ["0000-0001-6369-9961"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "PES's Rajaram and Tarabai Bandekar College of Pharmacy, Goa University, Ponda, India."}], "LastName": "Gurav", "ForeName": "Nilambari S", "Initials": "NS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, R.T.M. University, Nagpur, India."}], "LastName": "Prasad", "ForeName": "Rupali S", "Initials": "RS"}, {"Identifier": ["0000-0001-5564-2121"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Goa College of Pharmacy, Goa University, Panaji, India."}], "LastName": "Gurav", "ForeName": "Shailendra S", "Initials": "SS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "UR635J3F00", "NameOfSubstance": "saikosaponin D"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Saponins"}, {"QualifierName": [], "DescriptorName": "Spike Glycoprotein, Coronavirus"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., & Hao P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences, 63(3), 457\u2013460. 10.1007/s11427020-1637-5", "ArticleIdList": ["10.1007/s11427020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "Aanouz I., Belhassan A., El Khatabi K., Lakhlifi T., El Idrissi M., & Bouachrine M. (2020). Moroccan Medicinal plants as inhibitors of COVID-19:Computational investigations. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1758790", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Abdo A. E., & Eman B. A. (2020). Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1758789", "ArticleIdList": ["10.1080/07391102.2020.1758789", "PMC7189410", "32306854"]}, {"Citation": "Boopathi S., Poma A. B., & Kolandaivel P. (2020). Novel 2019 Coronavirus Structure, Mechanism of Action, Antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1758788", "ArticleIdList": ["10.1080/07391102.2020.1758788", "PMC7196923", "32306836"]}, {"Citation": "Bosch B. J., Van der Zee R., de Haan C. A., & Rottier P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801\u20138811. 10.1128/JVI.77.16.8801-8811.2003", "ArticleIdList": ["10.1128/JVI.77.16.8801-8811.2003", "PMC167208", "12885899"]}, {"Citation": "Chan J. F.-W., Yuan S., Kok K.-H., To K. K.-W., Chu H., Yang J., Xing F., Liu J., Yip C. C.-Y., Poon R. W.-S., Tsoi H.-W., Lo S. K.-F., Chan K.-H., Poon V. K.-M., Chan W.-M., Ip J. D., Cai J.-P., Cheng V. C.-C., Chen H., Hui C. K.-M., & Yuen K.-Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet, 395(10223), 514\u2013523. 10.1016/S0140-6736(20)30154-9", "ArticleIdList": ["10.1016/S0140-6736(20)30154-9", "PMC7159286", "31986261"]}, {"Citation": "Chen F., Chan K. H., Jiang Y., Kao R. Y., Lu H. T., Fan K. W., Cheng V. C., Tsui W. H., Hung I. F., Lee T. S., Guan Y., Peiris J. S., & Yuen K. Y. (2004). In-vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Journal of Clinical Virology, 31(1), 69\u201375. 10.1016/j.jcv.2004.03.003", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Chen H., & Du Q. (2020). Potential natural compounds for preventing 2019-nCoV infection. Preprints, 2020, 2020010358 10.20944/preprints202001.0358.v3", "ArticleIdList": ["10.20944/preprints202001.0358.v3"]}, {"Citation": "Chen J., Duan M., Zhao Y., Ling F., Xiao K., Li Q., Li B., Lu C., Qi W., Zeng Z., Liao M., Liu Y., & Chen W. (2015). Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Oncotarget, 6(40), 42541\u201342556. 10.18632/oncotarget.6448", "ArticleIdList": ["10.18632/oncotarget.6448", "PMC4767451", "26637810"]}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G., Liew O. W., Zhu W., Puah C. M., Shen X., & Jiang H. (2006). Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): Structure-activity relationship studies reveal salient pharmacophore features. Bioorganic and Medicinal Chemistry, 14(24), 8295\u20138306. 10.1016/j.bmc.2006.09.014", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Chen Y., Guo Y., Pan Y., & Zhao Z. J. (2020). Structure analysis of the receptor binding of 2019-nCoV. Biochemical and Biophysical Research Communications, 17(20), 30339\u201330339. 10.1016/j.bbrc.2020.02.071", "ArticleIdList": ["10.1016/j.bbrc.2020.02.071", "PMC7092824", "32081428"]}, {"Citation": "Cheng P. W., Ng L. T., Chiang L. C., & Lin C. C. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in\u00a0vitro. Clinical and Experimental Pharmacology and Physiology, 33(7), 612\u2013216. 10.1111/j.1440-1681.2006.04415.x", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., & Doerr H. W. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet, 361(9374), 2045\u20132046. 10.1016/S0140-6736(03)13615-X", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Deng X., Hackbart M., Mettelman R. C., O\u2019Brien A., Mielech A. M., Yi G., Kao C. C., & Baker S. C. (2017). Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proceedings of the National Academy of Sciences, 114(21), E4251\u2013E4260. 10.1073/pnas.1618310114", "ArticleIdList": ["10.1073/pnas.1618310114", "PMC5448190", "28484023"]}, {"Citation": "Elmezayen A., Al-Obaidi A., \u015eahin A. T., & Yelek\u00e7i K. (2020). Drug repurposing for coronavirus (COVID-19): Insilico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1758791", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Enayatkhani M., Hasaniazad M., Faezi S., Guklani H., Davoodian P., Ahmadi N., Einakian M. A., Karmostaji A., & Ahmadi K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1756411", "ArticleIdList": ["10.1080/07391102.2020.1756411", "PMC7196925", "32295479"]}, {"Citation": "Goswami T., & Bagchi B. (2020). Molecular docking study of receptor binding domain of SARS-CoV-2 spike glycoprotein with saikosaponin, a triterpenoid natural product. Preprints 2020. 10.26434/chemrxiv.12033774.v1", "ArticleIdList": ["10.26434/chemrxiv.12033774.v1"]}, {"Citation": "Gupta M. K., Vemula S., Donde R., Gouda G., Behera L., & Vadde R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1751300", "ArticleIdList": ["10.1080/07391102.2020.1751300", "PMC7171389", "32238078"]}, {"Citation": "Hasan A., Paray B. A., Hussain A., Qadir F. A., Attar F., Aziz F. M., Sharifi M., Derakhshankhah H., Rasti B., Mehrabi M., Shahpasand K., Saboury A. A., & Falahati M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1754293", "ArticleIdList": ["10.1080/07391102.2020.1754293", "PMC7189411", "32274964"]}, {"Citation": "Huang W., Zheng X., Yang X., & Fan S. (2017). Stimulation of osteogenic differentiation by saikosaponin-A in bone marrow stromal cells Via WNT/beta-catenin pathway. Calcified Tissue International, 100(4), 392\u2013401. 10.1007/s00223-017-0242-y", "ArticleIdList": ["10.1007/s00223-017-0242-y", "28185033"]}, {"Citation": "Khan R. J., Kumar Jha R., Muluneh Amera G., Jain M., Singh E., Pathak A., Singh R. P., Muthukumaran J., & Singh A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2\u2032-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1753577", "ArticleIdList": ["10.1080/07391102.2020.1753577", "PMC7189412", "32266873"]}, {"Citation": "Khan S. A., Zia K., Ashraf S., Uddin R., & Ul-Haq Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1751298", "ArticleIdList": ["10.1080/07391102.2020.1751298", "32238094"]}, {"Citation": "Li C. C., Wang X. J., & Wang H. R. (2019). Repurposing host-based therapeutics to control coronavirus and influenza virus. Drug Discovery Today, 24(3), 726\u2013736. 10.1016/j.drudis.2019.01.018", "ArticleIdList": ["10.1016/j.drudis.2019.01.018", "PMC7108273", "30711575"]}, {"Citation": "Li F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237\u2013261. 10.1146/annurev-virology-110615-042301", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K. S. M., Lau E. H. Y., Wong J. Y., Xing X., Xiang N., Wu Y., Li C., Chen Q., Li D., Liu T., Zhao J., Liu M., \u2026 Feng Z. (2020). Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. New England Journal of Medicine, 382(13), 1199\u20131207. 2610.1056/NEJMoa2001316", "ArticleIdList": ["10.1056/NEJMoa2001316", "PMC7121484", "31995857"]}, {"Citation": "Li X. Q., Song Y. N., Wang S. J., Rahman K., Zhu J. Y., & Zhang H. (2018. b). Saikosaponins: A review of pharmacological effects. Journal of Asian Natural Products Research, 20(5), 399\u2013411. 10.1080/10286020.2018.1465937", "ArticleIdList": ["10.1080/10286020.2018.1465937", "29726699"]}, {"Citation": "Li X., Li X., Huang N., Liu R., & Sun R. (2018. a). A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine, 50, 73\u201387. 1510.1016/j.phymed.2018.09.174", "ArticleIdList": ["10.1016/j.phymed.2018.09.174", "PMC7126585", "30466994"]}, {"Citation": "Lin C. W., Tsai F. J., Tsai C. H., Lai C. C., Wan L., Ho T. Y., Hsieh C. C., & Chao P. D. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research, 68(1), 36\u201342. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Lin L. T., Chung C. Y., Hsu W. C., Chang S. P., Hung T. C., Shields J., Russell R. S., Lin C. C., Li C. F., Yen M. H., Tyrrell D. L., Lin C. C., & Richardson C. D. (2015). Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Journal of Hepatology, 62(3), 541\u2013548. 10.1016/j.jhep.2014.10.040", "ArticleIdList": ["10.1016/j.jhep.2014.10.040", "25450204"]}, {"Citation": "Liu X., Zhang B., Jin Z., Yang H., & Rao Z. (2020). The crystal structure of COVID-19 main protease in complex with an inhibitor N3. 10.2210/pdb6LU7/pdb", "ArticleIdList": ["10.2210/pdb6LU7/pdb"]}, {"Citation": "Muralidharan N., Sakthivel R., Velmurugan D., & Gromiha M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1752802", "ArticleIdList": ["10.1080/07391102.2020.1752802", "32248766"]}, {"Citation": "Ortega J. T., Serrano M. L., Pujol F. H., & Rangel H. R. (2020). Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target. EXCLI Journal, 19, 400\u2013409. 10.17179/excli2020-1189", "ArticleIdList": ["10.17179/excli2020-1189", "PMC7081067", "32210741"]}, {"Citation": "Pant S., Singh M., Ravichandiran V., Murty U. S. N., & Srivastava H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1757510", "ArticleIdList": ["10.1080/07391102.2020.1757510", "PMC7212534", "32306822"]}, {"Citation": "Sarma P., Sekhar N., Prajapat M., Avti P., Kaur H., Kumar S., Singh S., Kumar H., Prakash A., Prasad Dhibar D., & Medhi B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics. 10.1080/07391102.2020.1753580", "ArticleIdList": ["10.1080/07391102.2020.1753580", "PMC7256351", "32266867"]}, {"Citation": "Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., & Qin C. (2019). From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11(1), 59 10.3390/v11010059", "ArticleIdList": ["10.3390/v11010059", "PMC6357155", "30646565"]}, {"Citation": "Walls A. C., Tortorici M. A., Snijder J., Xiong S., Bosch B. J., Rey F. A., & Veesler D. (2017). Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proceedings of the National Academy of Sciences, 114(42), 11157\u201311162. 10.1073/pnas.1708727114", "ArticleIdList": ["10.1073/pnas.1708727114", "PMC5651768", "29073020"]}, {"Citation": "World Health Organization.  (2020). Coronavirus Disease (COVID-2019)\nhttps://who.sprinklr.com"}, {"Citation": "Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., & Wang F.-S. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 8(4), 420\u2013422. 10.1016/S2213-2600(20)30076-X", "ArticleIdList": ["10.1016/S2213-2600(20)30076-X", "PMC7164771", "32085846"]}, {"Citation": "Yang H., Chen X., Jiang C., He K., & Hu Y. (2017). Antiviral and immunoregulatory role against PCV2 in-vivo of Chinese herbal medicinal ingredients. Journal of Veterinary Research, 61(4), 405\u2013410. 10.1515/jvetres-2017-0062", "ArticleIdList": ["10.1515/jvetres-2017-0062", "PMC5937337", "29978102"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32345124", "PMC7232888", "10.1080/07391102.2020.1762741"]}}]}